InsidersTradesSigma
Track the 에이비엘바이오 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 에이비엘바이오 has recorded 69 public disclosures. Market capitalisation: €3,963.9bn. The latest transaction was filed on 6 July 2026 (Other). Among the most active insiders: LEESANGHOON. Every trade is free.
69
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
38 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,641 of 29,055 companies
35.0
score / 100
Value31
Quality40
FCF yld-1.6%
Earn yld-0.9%
EV/EBITDA·
ROE-15%
Gross mgn100%
Net mgn-48%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
Declarations69 total
0KRXDART:20260403003473
687,000 sharesKRXDART:20251205000487
173,533 sharesKRXDART:20250404004101
35,000 sharesShareKRXDART:20250207000891
10,679 sharesKRXDART:20250103000564
21,000 sharesKRXDART:20241008000559
2,316,762 sharesKRXDART:20240905000405
8,000 sharesKRXDART:20240830002194
4,408,440 sharesKRXDART:20240719000482
0KRXDART:20240705000157
8,000 sharesKRXDART:20240701000228
382,737 sharesKRXDART:20240405003343
9,633 sharesKRXDART:20240405003288
8,000 sharesKRXDART:20231006000533
25 of 69 declarations
关于 에이비엘바이오
在XKRX市场上市的 ABLE Bio 专注于医疗保健和制药领域。该公司致力于开发针对各种疾病的创新疗法。